Couldn’t find an up to date thread on this
Seems to me like they’ve been crushing it since the financial crisis, but I’m wondering how this has been reflected in terms of the firm’s prestige and exit opps as of 2018
| +146 | UBS Catastrophic Q1-Q3 26, M&A -17%, Outside Top 10 in Americas, EMEA & APAC | 45 | 1h |
| +64 | PWP acquisition by Piper cancelled | 25 | 51m |
| +43 | No return offer - UPDATE. | 12 | 1d |
| +31 | Evercore poaches Baird DC Defense Team | 24 | 15h |
| +24 | Is my MD a grifter? 16 years, 8 firms | 13 | 12h |
| +23 | Article: UBS Wall Street Rebuild Is a Study in Management Failure | 5 | 26m |
| +22 | Best Houston Banks for Culture in 2026 | 17 | 10h |
| +21 | Lack of talent in IB! | 19 | 1d |
| +21 | Internal lateral from coverage to M&A (focused on coverage) | 6 | 2h |
| +15 | Discussion Transaction Experience in Lateral Interviews | 4 | 16h |
Career Resources
Get instant access to lessons taught by experienced private equity pros and bulge bracket investment bankers including financial statement modeling, DCF, M&A, LBO, Comps and Excel Modeling.
It's very solid. If you do a little LinkedIn research, you'll see that pretty much all groups are good enough to get looks. Plenty of solid MM PE exits across almost every group. Reasonably consistent MF PE exits are really only M&A, FIG, and Healthcare (this perspective comes from JPM people that I've actually talked to, not just LinkedIn). There are a couple MF placements from other groups that are obvious rockstars.
This forum generally seems to regard it a bit lower than GS and MS though... Does this still stand?